Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 29 Aug 2025 for iTeos Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Yvonne McGrath: trading record in brief
Yvonne McGrath (senior executive) discloses dealings in iTeos Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 17 May 2021 to 29 August 2025, the count stands at 19 filings.
On the market, this insider has only sold: 9 sales, €1.0M in total. The rest of the record consists of 2 share grants and 7 option exercises.
On 29 August 2025 came the latest disclosure, a transaction in iTeos Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Yvonne McGrath
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
46,300 sharesCommon StockSEC:0000950170-25-112235:0
15,300 shares0Common StockSEC:0000950170-25-037513:0
31,000 shares0Common StockSEC:0000950170-23-068903:0
10,000 shares@ US$4.2413.4% of flowCommon StockSEC:0001209191-22-015080:0
7,927 shares@ US$4.2318.8% of flowCommon StockSEC:0000899243-21-023000:0
7,927 shares@ US$4.239.7% of flowCommon StockSEC:0000899243-21-021779:0
7,604 shares@ US$4.2317.9% of flowCommon StockSEC:0000899243-21-021777:0
7,927 shares@ US$4.2315.8% of flowCommon StockSEC:0000899243-21-020733:0
7,926 shares@ US$4.2315.8% of flowCommon StockSEC:0000899243-21-019921:0
9 of 9 declarations
